With your support, we have been able to fund outstanding research, leading toward cures and improved quality of life for children with cancer. Browse through our nearly 1,000 funded projects below.
Use the search tool to refine your results. You can also click on a heading to sort by project title, institution name, or year the grant was awarded. Click on the project title to read more information.
ALSF Funded Research Projects
|Project Title||Institution / Principal Investigator(s)||Grant Type||Year||State|
|Adoptive immunotherapy using clinical-grade T cells.||University of Texas M.D. Anderson Cancer Center / Laurence Cooper, MD, PhD||Innovation Grants||2007||Texas|
|Multispecific T Cells for Adoptive Immunotherapy of Pediatric High Grade Glioma (HGG)||Baylor College of Medicine / Nabil Ahmed, MD, MSc||Innovation Grants||2013||Texas|
|Engager T cells for the Adoptive Immunotherapy of Pediatric Malignancies||Baylor College of Medicine / Stephen Gottschalk, MD||Innovation Grants||2013||Texas|
|Genetic Analysis of Pediatric Gliomas||Baylor College of Medicine / Will Parsons, MD, PhD||'A' Award Grants||2009||Texas|
|Immunotherapy of Neuroblastoma with CAR.GD2 NKT Cells||Baylor College of Medicine / Leonid S. Metelitsa, M.D., Ph.D.||Bio-Therapeutic Impact Award||2014||Texas|
|Pediatric Sarcoma, Rhabdomyosarcoma, and Mechanisms of Origin||University of Texas Southwestern Medical Center / Rene Galindo||'A' Award Grants||2010||Texas|
|Texas Children's Cancer Center Alex's Lemonade Stand Center of Excellence||Baylor College of Medicine / Stacey Berg, MD - Scholars: Jennifer Foster, MD, MPH and Ron Bernardi, MD,PhD||Center of Excellence Grants||2012||Texas|
|DICER1-Driven Cancers: Models, Mechanisms and Therapies||University of Texas Southwestern Medical Center at Dallas / James Amatruda, MD/PhD||Innovation Grants||2016||Texas|
|Energy Balance Strategies for Decreasing Chemotherapy-Induced Cardiotoxicity||University of Texas M.D. Anderson Cancer Center / Eugenie Kleinerman, MD/PhD||Innovation Grants||2018||Texas|
|Combining Oncolytic Vaccinia Virus with GD2.CAR-modified Vaccinia Virus-specific T-cells for the Treatment of Relapsed Neuroblastoma and Sarcoma||Baylor College of Medicine / Cliona Rooney, PhD||Reach Grants||2013||Texas|